[HTML][HTML] SARS-CoV-2 infections in children: Understanding diverse outcomes

P Brodin - Immunity, 2022 - cell.com
SARS-CoV-2 infections mostly lead to mild or even asymptomatic infections in children, but
the reasons for this are not fully understood. More efficient local tissue responses, better …

Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion

A Mazzoni, L Salvati, L Maggi, F Annunziato… - Seminars in …, 2021 - Elsevier
One and half year following the occurrence of COVID-19 pandemic, significant efforts from
laboratories all over the world generated a huge amount of data describing the prototypical …

Distinguishing multisystem inflammatory syndrome in children from COVID-19, Kawasaki disease and toxic shock syndrome

S Godfred-Cato, JY Abrams… - The Pediatric …, 2022 - journals.lww.com
Background: Distinguishing multisystem inflammatory syndrome in children (MIS-C) from
coronavirus disease 2019 (COVID-19), Kawasaki disease (KD), and toxic shock syndrome …

Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection

NJ Silverstein, Y Wang, Z Manickas-Hill, C Carbone… - Elife, 2022 - elifesciences.org
Background: Risk of severe COVID-19 increases with age, is greater in males, and is
associated with lymphopenia, but not with higher burden of SARS-CoV-2. It is unknown …

Multisystem inflammatory syndrome in children (MIS-C): a mini-review

M Giacalone, E Scheier, I Shavit - International Journal of Emergency …, 2021 - Springer
Multisystem inflammatory syndrome in children (MIS-C) is a novel, life-threatening
hyperinflammatory condition that develops in children a few weeks after infection with …

Timely recognition and early multi-step antinflammatory therapy may prevent ICU admission of patients with MIS-C: proposal for a severity score

G Brisca, A Consolaro, R Caorsi, D Pirlo, G Tuo… - Frontiers in …, 2021 - frontiersin.org
In this observational study, we report the clinical, therapeutics and outcome features of 23
patients with multisystem inflammatory syndrome (MIS-C) who have been treated in Gaslini …

Longitudinal outcomes and monitoring of patients with multisystem inflammatory syndrome in children

MA Fremed, KM Farooqi - Frontiers in Pediatrics, 2022 - frontiersin.org
The acute manifestations and short-term outcomes of multisystem inflammatory syndrome
(MIS-C) have been extensively described; however, our understanding of the longitudinal …

Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

KI Stevens, E Frangou, JI Shin… - Nephrology Dialysis …, 2022 - academic.oup.com
Patients with immune-mediated kidney diseases are at increased risk of severe coronavirus
disease 2019 (COVID-19). The international rollout of COVID-19 vaccines has provided …

From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and multisystem …

R Root-Bernstein - International Journal of Molecular Sciences, 2023 - mdpi.com
Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many
measures of increased inflammation in severe COVID-19 that also accompany its …

Gastrointestinal perspective of coronavirus disease 2019 in children—an updated review

A Assa, MA Benninga, O Borrelli… - Journal of Pediatric …, 2021 - journals.lww.com
Gastrointestinal symptoms are common findings in children with severe acute respiratory
syndrome coronavirus 2 infection, including vomiting, diarrhoea, abdominal pain, and …